| Bayer (Schweiz) AG - Magnevist, Injektionslösung |
| 49186 | | 01 | | Magnevist | | Injektionslösung | | V08CA01 | | Gadopentetsäure | | 19.09.1988 | | |
|
| Composition |
| dimeglumini gadopentetas 469 mg, megluminum, acidum penteticum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | Principe actif | Concentr. |
|---|
| Dimeglumine Gadopentetate | 469 mg/ml |
|
|
|
